BMGLNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends June 30
Basel Medical Group Ltd
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 18, 2025
$4.05+0.10 (+2.53%)
Close on Oct 19, 2026
Ownership
Who owns Basel Medical's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Rainforest Capital VCC | 10,174,579 | 54.20% | 13G (passive) | Feb 21, 2025 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Boon Chye Tan | Chief Commercial Officer, Director | 10,205,229 | 54.32% | Apr 14, 2026 |
| Alton Chun How Neo | Interim CFO | – | – | Jul 22, 2026 |
| Jianing JN Lu | Chief Financial Officer | – | – | Apr 15, 2026 |
| Darren Yen Feng Chhoa | Chief Executive Officer | – | – | Apr 14, 2026 |
| Kwek Yoon Soong | Director | – | – | Apr 21, 2026 |
| Tony Chen | Director | – | – | Apr 14, 2026 |
| Keng Leong Fung | Director | 10,205,229 | 54.32% | Apr 14, 2026 |
| Paul D. Freudenthaler | Director | – | – | Mar 4, 2026 |